JANET ZALANSKAS: Open Payments
NPI 1609886340 · SCARBOROUGH, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 54 payments from 11 companies in 2025. Trend: 2023 $2,480 · 2024 $1,180 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $284 |
| E.R. Squibb & Sons, L.L.C. | 9 | $160 |
| Teva Pharmaceuticals USA, Inc. | 7 | $141 |
| Lundbeck LLC | 4 | $108 |
| ABBVIE INC. | 4 | $94 |
| Alkermes, Inc. | 4 | $82 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
Products named: FANAPT, COBENFY, AUSTEDO XR, REXULTI, VRAYLAR, Auvelity, CAPLYTA, INGREZZA.
Industry payments across ME — which companies pay providers there.
